Kernel’s Post

ICYMI, Kernel’s summer newsletter was recently released. If you’re looking for the most efficient way to keep up on all things Kernel, the newsletter is where it’s at. 💜 The latest news → https://lnkd.in/gH9udxdg 📥 Subscribe here → https://lnkd.in/gPBt-ypT

🚀 We are proud to announce that Kernel was selected in the inaugural cohort of the StartUp Health Alzheimer’s Moonshot, a collaborative community supported by Gates Ventures and the Alzheimer's Drug Discovery Foundation (ADDF). What does this mean? The Alzheimer’s Moonshot program is a group of innovative companies working across the care continuum to improve the way that patients with Alzheimer’s Disease and Related Dementias are screened, diagnosed, treated, and cared for. Read about the work Kernel is doing as part of this exceptional group: https://lnkd.in/gbJAzDnW

There are only 5 days left to cast your vote for #SXSW 2025 #PanelPicker. We'd love your vote for our proposals on #mentalhealth and #MCI / healthy #aging. The Future of Mental Health: Precision Neuromedicine: VOTE: https://lnkd.in/g2PXc4-r Featuring: Samantha Tabone, Partner, Focalpoint Partners 💊 Sam Banister, CSO & Co-founder, Psylo Jacob Robinson, CEO & Co-Founder, Motif Neurotech Ryan Field, CEO & CTO, Kernel Detecting and Delaying the Onset of Cognitive Decline: VOTE: https://lnkd.in/gBBjdMit Featuring Phyllis Ferrell, Chief Impact Officer, StartUp Health #AlzMoonshot Ken Mariash, CEO, Sinaptica Therapeutics Jen Flexman, PhD, MBA, COO & Co-founder, Moneta Health Ryan Field, CEO & CTO, Kernel

Don't miss our CEO, Ryan Field, at #HLTH2024!

✍️ Kernel has just published a new study about the reliability of cortical #brain metrics in Scientific Reports from Nature Portfolio! 🧠 Using our Flow2 brain measurement system, we found good reliability in several brain metrics within the same day, on different days, and using different headsets. 🧱 Reliability benchmarking often gets neglected, but we believe that solid research findings can only be built on reliable measurements. Understanding the factors that do and don’t affect measurement stability allow for #neuroscience advances that can be trusted, and we are proud to contribute to the peer-reviewed literature on this topic. We look forward to building on this foundation as we execute clinical partnership and develop our own clinical tools. Read the full paper here → https://lnkd.in/gepueyd4

Less than two weeks out from the Alzheimer's Association® International Conference in Philadelphia! AAIC is the largest conference on #dementia research and Kernel is proud to take part. 💜 Ryan Field and Katherine Perdue will be sharing Kernel's latest work using our Flow2 brain measurement system. We are excited to have Katherine present our findings in the poster “Developing a novel brain-based biomarker of mild cognitive impairment using time-domain functional near-infrared spectroscopy." Connect with our team if you’ll be in Philly and want to experience a demo or learn more about our biomarker for #MCI based on functional brain measurements. #AAIC24 #Alzheimers